Terms: = Thyroid cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
333 results:
1. Influence of different pH milieu on the structure and function of human Aurora kinase B protein (AURK-B): Amalgamation of both spectroscopic and computational approach.
Gupta D; Kumari R; Kumar M; Singh M; Rawat S; Ethayathulla AS; Kaur P
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 312():124047. PubMed ID: 38394881
[TBL] [Abstract] [Full Text] [Related]
2. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
Xiao X; Wu X; Yi L; You F; Li X; Xiao C
Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
[TBL] [Abstract] [Full Text] [Related]
3. Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata.
Zheng XY; Ma YP; Zhang B; Chen YX; Tang L; Tai XH; Cao JH
Front Endocrinol (Lausanne); 2023; 14():1309620. PubMed ID: 38292771
[TBL] [Abstract] [Full Text] [Related]
4. The Immune Suppressor IGSF1 as a Potential Target for cancer Immunotherapy.
Koh DI; Lee M; Park YS; Shin JS; Kim J; Ryu YS; Lee JH; Bae S; Lee MS; Hong JK; Jeong HR; Choi M; Hong SW; Kim DK; Lee HK; Kim B; Yoon YS; Jin DH
Cancer Immunol Res; 2024 Apr; 12(4):491-507. PubMed ID: 38289363
[TBL] [Abstract] [Full Text] [Related]
5. Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data.
Wang P; Zhang Q; Zhang H; Shao J; Zhang H; Wang Z
PLoS One; 2023; 18(12):e0293469. PubMed ID: 38127899
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance and immune landscape of angiogenesis-related genes in bladder cancer.
Liu G; Zhang T; Gui D; Liu Q
Aging (Albany NY); 2023 Nov; 15(22):13118-13133. PubMed ID: 37988196
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside.
Dos Santos Valsecchi VA; Betoni FR; Ward LS; Cunha LL
Rev Endocr Metab Disord; 2024 Feb; 25(1):5-17. PubMed ID: 37889392
[TBL] [Abstract] [Full Text] [Related]
8. [Attempt to Evaluate the Influence of Morphology, Blood Flow, and Hardness in Mammary Gland Malignant Disease].
Horita H; Narumi A; Kamada M; Ogasawara K
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Nov; 79(11):1287-1292. PubMed ID: 37839866
[TBL] [Abstract] [Full Text] [Related]
9. Endocrine immune-related adverse effects of immune-checkpoint inhibitors.
Trevisani V; Iughetti L; Lucaccioni L; Predieri B
Expert Rev Endocrinol Metab; 2023; 18(5):441-451. PubMed ID: 37682107
[TBL] [Abstract] [Full Text] [Related]
10. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract] [Full Text] [Related]
11. Machine learning-aided metallomic profiling in serum and urine of thyroid cancer patients and its environmental implications.
Chen Z; Liu X; Wang W; Zhang L; Ling W; Wang C; Jiang J; Song J; Liu Y; Lu D; Liu F; Zhang A; Liu Q; Zhang J; Jiang G
Sci Total Environ; 2023 Oct; 895():165100. PubMed ID: 37356765
[TBL] [Abstract] [Full Text] [Related]
12. Association between thyroid cancer and ctla-4 Gene Polymorphisms.
Sun L; Niu T; Zhang Y
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):31-36. PubMed ID: 37329551
[TBL] [Abstract] [Full Text] [Related]
13. Toxicities associated with immune checkpoint inhibitors: a systematic study.
Kong X; Chen L; Su Z; Sullivan RJ; Blum SM; Qi Z; Liu Y; Huo Y; Fang Y; Zhang L; Gao J; Wang J
Int J Surg; 2023 Jun; 109(6):1753-1768. PubMed ID: 37132038
[TBL] [Abstract] [Full Text] [Related]
14. A novel immune score model predicting the prognosis and immunotherapy response of breast cancer.
Lv W; He X; Wang Y; Zhao C; Dong M; Wu Y; Zhang Q
Sci Rep; 2023 Apr; 13(1):6403. PubMed ID: 37076508
[TBL] [Abstract] [Full Text] [Related]
15. Usefulness of cranio-dorsal approach for laparoscopic left lateral sectionectomy.
Kawasaki Y; Yamasaki Y; Idichi T; Oi H; Kurahara H; Mataki Y; Ueno S; Ohtsuka T
Updates Surg; 2023 Jun; 75(4):889-895. PubMed ID: 37061652
[TBL] [Abstract] [Full Text] [Related]
16. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
[TBL] [Abstract] [Full Text] [Related]
17. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract] [Full Text] [Related]
18. The specific phagocytosis regulators could predict recurrence and therapeutic effect in thyroid cancer: A study based on bioinformatics analysis.
Hou C; Wu M; Zhang H; Yang Z
Medicine (Baltimore); 2023 Mar; 102(11):e33290. PubMed ID: 36930113
[TBL] [Abstract] [Full Text] [Related]
19. Highly sensitive detection of thyroglobulin based on sandwich-type electrochemical immunoassay.
Zhang H; Lin Z; Li Y; Lin Z; Yang S; Qiu B; Yu M
Anal Sci; 2023 Jun; 39(6):969-975. PubMed ID: 36877338
[TBL] [Abstract] [Full Text] [Related]
20. Management of immune-mediated toxicities and their implications in the outcomes of advanced kidney cancer.
Roy AM; George S
Immunotherapy; 2023 Apr; 15(6):397-400. PubMed ID: 36861344
[TBL] [Abstract] [Full Text] [Related]
[Next]
